Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-25-001181
Filing Date
2025-01-06
Accepted
2025-01-06 16:30:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 14188
2 JOINT FILING AGREEMENT DATED JANUARY 6, 2025 BY AND BETWEEN THE REPORTING PERSON ea022686101ex1_bgm.htm EX-1 7211
3 LIST OF DIRECTORS AND EXECUTIVE OFFICERS OF (I) AIX INC. AND (II) CISG HOLDINGS ea022686101ex2_bgm.htm EX-2 9503
  Complete submission text file 0001213900-25-001181.txt   33332
Mailing Address 60/F PEARL RIVER TOWER NO.15 WEST ZHUJIANG ROAD TIANHE DISTRICT GUANGZHOU F4 510623
Business Address 60/F PEARL RIVER TOWER NO.15 WEST ZHUJIANG ROAD TIANHE DISTRICT GUANGZHOU F4 510623 (86-20) 8388 6888
AIX Inc. (Filed by) CIK: 0001413855 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13D
SIC: 6411 Insurance Agents, Brokers & Service
(CF Office: 02 Finance)

Mailing Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200
Business Address NO. 152 HONGLIANG EAST 1ST STREET NO. 1703, TIANFU NEW DISTRICT CHENGDU F4 610200 86-028-64775180
BGM Group Ltd. (Subject) CIK: 0001779578 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0930
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92136 | Film No.: 25511597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)